Results 211 to 220 of about 8,475,584 (303)

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

РазÑабоÑка бизнеÑ-плана пÑедпÑиÑÑиÑ

, 2017
Анастасия Сергеевна Цыганова
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Maternal Vitamin D Deficiency and Its Effects on Pregnancy Outcomes. [PDF]

Food Sci Nutr
Ibrahim Y, Mohd Jamil AA, Nordin N, Loh SP, Basri NI.   +4 more
europepmc   +1 more source

ЦÐТÐÐÐÐÐÐÐРСТÐТУС Ð¥ÐÐРÐÐ¥ ÐРХРÐÐÐЧÐÐÐ ÐÐÐÐТÐТ С ТРÐÐÐÐ ÐÐРÐÐЦÐЯ

, 2013
Г.М. Гевко
openalex   +2 more sources

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

NMNAT1 Activates Autophagy to Delay D-Galactose-Induced Aging in Cochlear Hair Cells. [PDF]

Aging Cell
Wei Y, Yang W, Wu H, Kong M, Fan D, Zhang Y, Cheng N, Du J, Guo L, Li Y, Zhang Y, Dai Q, Cao W, Yang J, Fang Q.   +14 more
europepmc   +1 more source

РÐÐРÐÐÐРТРÐÐÐÐÐÐЦÐЯ ÐÐТÐÐÐÐÐ ÐÐÐЬÐÐСÐÐÐÐ ÐÐÐÐÐЧÐÐÐЯ ÐÐТÐÐÐÐÐ¥ ФÐРÐÐЦÐÐТÐЧÐÐÐ¥ ÐÐÐРÐÐÐÐÐТÐÐ Ð ÐРÐÐЬÐÐРСУСÐÐÐÐÐР«ÐÐ-ТÐл

, 2014
А. В. Глущенко, А. М. Шекель, І. А. Вишневський, В. А. Георгіянц   +3 more
openalex   +2 more sources

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

The Relationship between Type D Personality and Depression Symptoms in Stroke Patients: The Chain Mediating Effect of Self-Efficacy and Participation Preferences. [PDF]

Brain Behav
Zhang H, Yu S, Ye Y.
europepmc   +1 more source